The global health ecosystem’s unified effort in fighting the unparalleled challenge presented by COVID-19 will be the subject of expert discussions at Frontiers Health’s Fight The Pandemic
COVID-19 has left no part of life untouched, including health technology assessment (HTA) and other payer agency activities, and it will likely have a lasting impact on market access.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
